Journal of Clinical Medicine (Mar 2021)

Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy

  • Quirino Ciampi,
  • Iacopo Olivotto,
  • Jesus Peteiro,
  • Maria Grazia D’Alfonso,
  • Fabio Mori,
  • Luigi Tassetti,
  • Alessandra Milazzo,
  • Lorenzo Monserrat,
  • Xusto Fernandez,
  • Attila Pálinkás,
  • Eszter Dalma Pálinkás,
  • Róbert Sepp,
  • Federica Re,
  • Lauro Cortigiani,
  • Milorad Tesic,
  • Ana Djordjevic-Dikic,
  • Branko Beleslin,
  • Mariangela Losi,
  • Grazia Canciello,
  • Sandro Betocchi,
  • Luis Rocha Lopes,
  • Ines Cruz,
  • Carlos Cotrim,
  • Marco A. R. Torres,
  • Clarissa C. A. Bellagamba,
  • Caroline M. Van De Heyning,
  • Albert Varga,
  • Gergely Ágoston,
  • Bruno Villari,
  • Valentina Lorenzoni,
  • Clara Carpeggiani,
  • Eugenio Picano,
  • the Stress Echo 2020 Study Group on behalf of the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI)

DOI
https://doi.org/10.3390/jcm10071347
Journal volume & issue
Vol. 10, no. 7
p. 1347

Abstract

Read online

Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 ± 15 years, 516 men) assessed with exercise stress echocardiography (ESE) in 11 centres. ESE modality was semi-supine bicycle in 51 patients (6%), upright bicycle in 476 (52%), and treadmill in 390 (42%). During ESE, we assessed left ventricular outflow tract obstruction (LVOTO), stress-induced new regional wall motion abnormalities (RWMA), and HRR (peak/rest heart rate, HR). By selection, all patients completed the follow-up. Mortality was the predetermined outcome measure Results: During ESE, RWMA occurred in 22 patients (2.4%) and LVOTO (≥50 mmHg) in 281 (30.4%). HRR was 1.90 ± 0.40 (lowest quartile ≤ 1.61, highest quartile > 2.13). Higher resting heart rate (odds ratio 1.027, 95% CI: 1.018–1.036, p p p 0.001) and resting LVOTO (odds ratio 1.504, 95% CI: 1.043–2.170, p = 0.029) predicted a reduced HRR. During a median follow-up of 89 months (interquartile range: 36–145 months), 90 all-cause deaths occurred. At multivariable analysis, lowest quartile HRR (Hazard ratio 2.354, 95% CI 1.116–4.968 p = 0.025) and RWMA (Hazard ratio 3.279, 95% CI 1.441–7.461 p = 0.004) independently predicted death, in addition to age (Hazard ratio 1.064, 95% CI 1.043–1.085 p 0.001) and maximal wall thickness (Hazard ratio 1.081, 95% CI 1.037–1.128, p < 0.001). Conclusions: A blunted HRR during ESE predicts survival independently of RWMA in HCM patients.

Keywords